FR2100618A1 - - Google Patents

Info

Publication number
FR2100618A1
FR2100618A1 FR7109173A FR7109173A FR2100618A1 FR 2100618 A1 FR2100618 A1 FR 2100618A1 FR 7109173 A FR7109173 A FR 7109173A FR 7109173 A FR7109173 A FR 7109173A FR 2100618 A1 FR2100618 A1 FR 2100618A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7109173A
Other versions
FR2100618B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2100618A1 publication Critical patent/FR2100618A1/fr
Application granted granted Critical
Publication of FR2100618B1 publication Critical patent/FR2100618B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7109173A 1970-03-16 1971-03-16 Expired FR2100618B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2003470A 1970-03-16 1970-03-16

Publications (2)

Publication Number Publication Date
FR2100618A1 true FR2100618A1 (fr) 1972-03-24
FR2100618B1 FR2100618B1 (fr) 1974-08-23

Family

ID=21796376

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7109173A Expired FR2100618B1 (fr) 1970-03-16 1971-03-16

Country Status (14)

Country Link
AT (1) AT341116B (fr)
BE (1) BE764252A (fr)
CA (1) CA940530A (fr)
CH (2) CH590275A5 (fr)
DE (1) DE2111938A1 (fr)
DK (1) DK137189B (fr)
FR (1) FR2100618B1 (fr)
GB (1) GB1313963A (fr)
IE (1) IE35284B1 (fr)
IL (1) IL36400A (fr)
NL (1) NL7103506A (fr)
PH (1) PH9976A (fr)
SE (1) SE395699B (fr)
ZA (1) ZA711588B (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2292476A1 (fr) * 1973-12-07 1976-06-25 Hoffmann La Roche Derives de la quinoleine
FR2381044A1 (fr) * 1977-02-17 1978-09-15 Hoffmann La Roche Procede pour la preparation de mefloquine
EP0000302A1 (fr) * 1977-06-15 1979-01-10 Devinter S.A. Nouveau procédé de préparation de la quinidine.

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1212322A2 (fr) 1999-08-27 2002-06-12 Ligand Pharmaceuticals Incorporated Composes de 6-trifluoromethyl-9-pyrido[3,2-g]quinoline 8-substitues utilises comme modulateurs de recepteurs androgenes
WO2001016139A1 (fr) * 1999-08-27 2001-03-08 Ligand Pharmaceuticals Incorporated Composes de modulation du recepteur androgene et procedes d'utilisation
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
AU7586600A (en) 1999-09-14 2001-04-17 Ligand Pharmaceuticals Incorporated Rxr modulators with improved pharmacologic profile

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2012151A1 (fr) * 1968-07-02 1970-03-13 Hoffmann La Roche

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2012151A1 (fr) * 1968-07-02 1970-03-13 Hoffmann La Roche

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2292476A1 (fr) * 1973-12-07 1976-06-25 Hoffmann La Roche Derives de la quinoleine
FR2381044A1 (fr) * 1977-02-17 1978-09-15 Hoffmann La Roche Procede pour la preparation de mefloquine
EP0000302A1 (fr) * 1977-06-15 1979-01-10 Devinter S.A. Nouveau procédé de préparation de la quinidine.

Also Published As

Publication number Publication date
ZA711588B (en) 1971-12-29
FR2100618B1 (fr) 1974-08-23
DK137189B (da) 1978-01-30
IL36400A0 (en) 1971-05-26
DE2111938A1 (de) 1971-10-07
CH590275A5 (fr) 1977-07-29
IE35284L (en) 1971-09-16
CH590274A5 (fr) 1977-07-29
DK137189C (fr) 1978-07-03
IE35284B1 (en) 1976-01-07
PH9976A (en) 1976-06-16
BE764252A (fr) 1971-09-15
SE395699B (sv) 1977-08-22
CA940530A (en) 1974-01-22
AT341116B (de) 1978-01-25
IL36400A (en) 1973-07-30
GB1313963A (en) 1973-04-18
ATA220971A (de) 1977-05-15
NL7103506A (fr) 1971-09-20

Similar Documents

Publication Publication Date Title
AR204384A1 (fr)
DK137189C (fr)
AU1473870A (fr)
AU2044470A (fr)
AU2017870A (fr)
AU2085370A (fr)
AU1517670A (fr)
AU1326870A (fr)
AU1833270A (fr)
AU2130570A (fr)
AU1336970A (fr)
AR195465A1 (fr)
AU2115870A (fr)
AU1969370A (fr)
AU1789870A (fr)
AU1343870A (fr)
AU2144270A (fr)
AU1328670A (fr)
AU2130770A (fr)
AU1832970A (fr)
AU2119370A (fr)
AU1591370A (fr)
AU2112570A (fr)
AU1004470A (fr)
AU1841070A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse